PATENT CLAIM ANALYSIS

Application Number: 15866001
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
The present invention is related to a method for treating cancer metastasis and composition thereof. By using an IL-35 antagonist, cancer metastasis can be effectively treated so that an increased cancer fee and overall survival can be achieved.

Claim (Index 6):
The method of  claim 1 , wherein said anti-IL-35 antibody is a humanized antibody.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.24242
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13634392', '15402141', '14562306', '14478175', '14661656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7212255319715989
- 35 USC 102 Novelty (BERT): 0.5098636515279141
- Combined Prediction Score: 0.7000893439272304
- Mean Citation Score: 275.17931400000003
- Max Citation Score: 283.3375200000001
- Similarity Product: 204.8280970920039

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test